Pragmatic, Randomized Evaluation of Statin Active Choice to Reach Improved Outcomes Based on Evidence

In this study, the investigators will conduct a pragmatic, cluster-randomized, controlled trial to evaluate an active choice intervention with and without social comparison feedback to increase physician statin prescribing rates for eligible patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiovascular Diseases

Age range

40 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Pennsylvania Health System

Philadelphia, Pennsylvania, 19104, United States

About this study

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the United States. Strong evidence indicates that statin medications can reduce the risk of CVD and for those with CVD statins have been shown to reduce mortality. Despite this evidence, statins are under-prescribed. In this study, the investigators will test the effectiveness of nudges targeted to physicians using active choice and social comparisons feedback to increasing the rate at which statin medications are prescribed to patients eligible based on national practice guidelines.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patient has a primary care physician at University of Pennsylvania Health System
Patient meets 2013 AHA/ACC guidelines for statin therapy but no record of a statin prescription in the electronic health record

Exclusion criteria

Patient has an allergy or adverse reaction to statins documented in the electronic health record
Patient has glomerular filtration rate less than 30 mL/min
Physicians (and their respective patients) will be excluded if they have less than 10 patients among their entire panel that are eligible for a statin

Treatment and study plan

Active choice

Behavioral

Statin options are framed to physicians as an active choice to prescribe or not prescribe a statin

Social comparison feedback

Behavioral

Statin prescribing rates are communicated to physicians and along with how their performance compares to their peers

Primary outcomes

Statin Prescribing Rate

Time frame: Two Months

Percentage of patients eligible for a statin that have been prescribed a statin

Sponsors and collaborators

Lead sponsor

University of Pennsylvania

Other

Registry information

Acronym: PRESCRIBE

Important dates

Study start: 2017
Primary completion: 2017
Study completion: 2017
First posted: Jan 16, 2017
Registry last updated: Jun 20, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed